4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Pivotal Phase ◽

Release Formulation ◽

Hyperactivity Disorder ◽

6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.362 ◽

2016 ◽

Vol 55 (10) ◽

pp. S217-S218 ◽

Cited By ~ 1

Author(s):

Scott H. Kollins ◽

Andrew J. Cutler ◽

Sohail Khattak ◽

Margaret D. Weiss ◽

Graeme Donnelly ◽

...

Keyword(s):

Multicenter Study ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Double Blind ◽

Release Formulation ◽

Double Blind Placebo ◽

Effect of Delayed-Release and Extended-Release Methylphenidate on Caregiver Strain and Validation of Psychometric Properties of the Caregiver Strain Questionnaire: Results from a Phase 3 Trial in Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2020.0159 ◽

2021 ◽

Author(s):

Frank A. López ◽

Stephen V. Faraone ◽

Jeffrey H. Newcorn ◽

Helen A. Doll ◽

Stephanie Rhoten ◽

...

Keyword(s):

Psychometric Properties ◽

Attention Deficit ◽

Extended Release ◽

Caregiver Strain ◽

Phase 3 ◽

Hyperactivity Disorder ◽

Pharmacokinetics of a Guanfacine Extended-Release Formulation in Children and Adolescents with Attention-Deficit–Hyperactivity Disorder

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)79219-3 ◽

2009 ◽

Vol 2009 ◽

pp. 53-54

Author(s):

A. Mack

Keyword(s):

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Release Formulation ◽

6.49 PHARMACOKINETICS OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND IN HEALTHY ADULTS AT STEADY STATE

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.368 ◽

2016 ◽

Vol 55 (10) ◽

pp. S219-S220 ◽

Cited By ~ 1

Author(s):

Declan Martin Quinn ◽

Twyla D. Bode ◽

Graeme Donnelly ◽

Joseph L. Reiz

Keyword(s):

Steady State ◽

Attention Deficit ◽

Extended Release ◽

Healthy Adults ◽

Release Formulation ◽

A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2020.0005 ◽

2020 ◽

Vol 30 (9) ◽

pp. 549-557

Author(s):

Greg Mattingly ◽

Valerie Arnold ◽

Brian Yan ◽

Ming Yu ◽

Brigitte Robertson

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Low Dose ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

36.4 A Phase 3 Registration Trial of Delayed-Release and Extended-Release Methylphenidate (HLD200) in the Treatment of Early Morning Functioning Impairments in Children with Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.07.331 ◽

2016 ◽

Vol 55 (10) ◽

pp. S315

Author(s):

Steven R. Pliszka

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Early Morning ◽

Phase 3 ◽

Hyperactivity Disorder ◽

Delayed Release ◽

Registration Trial

Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2017.0084 ◽

2017 ◽

Vol 27 (6) ◽

pp. 474-482 ◽

Cited By ~ 13

Author(s):

Steven R. Pliszka ◽

Timothy E. Wilens ◽

Samantha Bostrom ◽

Valerie K. Arnold ◽

Andrea Marraffino ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Hyperactivity Disorder ◽

Pharmacokinetics of a Guanfacine Extended-Release Formulation in Children and Adolescents with Attention-Deficit–Hyperactivity Disorder

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.27.9.1253 ◽

2007 ◽

Vol 27 (9) ◽

pp. 1253-1262 ◽

Cited By ~ 34

Author(s):

Samuel W Boellner ◽

Michael Pennick ◽

Kimberly Fiske ◽

Andrew Lyne ◽

Amir Shojaei

Keyword(s):

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Release Formulation ◽

A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.05.021 ◽

2020 ◽

Vol 42 (8) ◽

pp. 1452-1466 ◽

Cited By ~ 2

Author(s):

Azmi Nasser ◽

Tesfaye Liranso ◽

Toyin Adewole ◽

Nicholas Fry ◽

Joseph T. Hull ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Controlled Trial ◽

Phase Iii ◽

School Age Children ◽

School Age ◽

Efficacy And Safety ◽

Once Daily ◽

Model-Based Approach for Establishing the Predicted Clinical Response of a Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder

Journal of Clinical Psychopharmacology ◽

10.1097/jcp.0000000000001222 ◽

2020 ◽

Vol 40 (4) ◽

pp. 350-358 ◽

Cited By ~ 1

Author(s):

Roberto Gomeni ◽

Marina Komolova ◽

Bev Incledon ◽

Stephen V. Faraone

Keyword(s):

Clinical Response ◽

Attention Deficit ◽

Extended Release ◽

Hyperactivity Disorder ◽

Model Based ◽